Cellectis S.A. (CLLS)
Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.
Address
8 RUE DE LA CROIX JARRY
PARIS, LLE-DE-FRANCE, I0 75013
Founded
1999
Number of Employees
221
Website
http://www.cellectis.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at CLLS make a trade.
Creating a free account takes less than one minute